All Articles

Multi-omics classification of acute myeloid leukemia guides drug combinations to overcome Venetoclax resistance

Evaluation of intracellular nucleotide pools in peripheral blood and bone marrow mononuclear cells and their association with frontline intensive chemotherapy response rates in AML patients

Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia

Unveiling T cell evasion mechanisms to immune checkpoint inhibitors in acute myeloid leukemia

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia

Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells

How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?

Targeting regulated cell death pathways in acute myeloid leukemia

Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironment

Venetoclax resistance: mechanistic insights and future strategies

Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication

Lysosome-mediated chemoresistance in acute myeloid leukemia

Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance

Resistance to venetoclax and hypomethylating agents in acute myeloid leukemia

Liquid biopsies in myeloid malignancies